0 (baseline) | 1–2 months | p-value1) | 3 months | p-value1) | 6 months | p-value2) | |
---|---|---|---|---|---|---|---|
CGAS 3) | 74.4 (± 16.5)4) | 86.9 (± 5.6) | 0.043 | 88.3 (± 9.2) | 0.006 | ||
HAM-D5) | 5.7 (± 7.3) | 0.3 (± 0.8) | 0.043 | 1.0 (± 1.3) | 0.009 | ||
HAM-A6) | 6.9 (± 6.9) | 0.1 (± 0.4) | 0.043 | 0.7 (± 1.3) | 0.010 | ||
BDI7) | 3.4 (± 6.5) | 0.0 (± 0.0) 8) | n.s.9) | 0.1 (± 0.4) | 0.041 | 0.6 (± 1.1) | 0.014 |
BAI10) | 3.0 (± 2.9) | 1.3 (± 1.5) 8) | n.s. | 0.7 (± 1.1) | 0.042 | 1.4 (± 2.2) | n.s. |
CBCL11) Total problems | 28.3 (± 12.8) | 18.4 (± 6.9) | 0.028 | 14.0 (± 9.5) | 0.028 | 18.4 (± 16.2) | 0.007 |
Anxious/depressed | 3.9 (± 3.1) | 1.4 (± 1.7) | 0.046 | 1.3 (± 1.5) | 0.026 | 1.3 (± 1.1) | 0.033 |
Aggressive behaviour | 7.3 (± 4.2) | 5.6 (± 2.2) | n.s. | 3.6 (± 3.1) | 0.039 | 6.0 (± 6.4) | 0.047 |
YSR12) Total problems | 24.4 (± 13.8) | 17.0 (± 12.5) | n.s. | 8.0 (± 7.8) | 0.018 | 9.4 (± 7.4) | 0.001 |
Anxious/depressed | 2.7 (± 3.4) | 1.6 (± 2.2) | n.s. | 0.3 (± 0.5) | 0.026 | 0.6 (± 1.0) | 0.002 |
Aggressive behaviour | 5.1 (± 2.7) | 4.1 (± 2.7) | n.s. | 2.0 (± 2.2) | 0.044 | 2.4 (± 1.4) | 0.021 |
Somatic complains | 4.9 (± 2.4) | 3.1 (± 2.3) | 0.038 | 2.1 (± 1.2) | 0.026 | 2.3 (± 2.1) | 0.003 |
S-EndoAbA8) | 800(200–1600) | 200 (5–400) | 0.018 | 5 (5–1600) | 0.027 | 5 (5–100) | 0.001 |
S-tTGAbA | 139 (± 158) | 30 (± 35) | 0.018 | 19 (± 26) | 0.018 | 7 (± 8) | < 0.001 |
Prolactin (mU/l)13) | 1569 (± 767) | 218 (± 60) | 0.028 | 284 (± 170) | 0.018 | 205 (± 92)14) | 0.019 |
S-T4/TSH (nmol/l:mU/l) | 34 (± 6) | 64 (± 38)14) | 0.043 | 84 (± 53) | 0.043 | 74 (± 32)15) | 0.039 |